Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Chemotherapy × Clear all

Status

Recruiting 2 Unknown 1 Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 1817 Neoplasms 1217 Colorectal Neoplasms 1035 Carcinoma, Non-Small-Cell Lung 988 Stomach Neoplasms 777 Carcinoma, Hepatocellular 777 Lung Neoplasms 748 Prostatic Neoplasms 678 Pancreatic Neoplasms 555 Rectal Neoplasms 439 Neoplasm Metastasis 402 Ovarian Neoplasms 397 Colonic Neoplasms 396 Uterine Cervical Neoplasms 392 Recurrence 380 Leukemia, Myeloid, Acute 370 Esophageal Neoplasms 344 Multiple Myeloma 335 Lymphoma 327 Head and Neck Neoplasms 321 Melanoma 305 Precursor Cell Lymphoblastic Leukemia-Lymphoma 283 Brain Neoplasms 262 Urinary Bladder Neoplasms 246 Nasopharyngeal Carcinoma 224 Liver Neoplasms 219 Leukemia 215 Lymphoma, Large B-Cell, Diffuse 214 Squamous Cell Carcinoma of Head and Neck 204 Polycystic Ovary Syndrome 203

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03701607 2018-10-10

Effect of Chemotherapy on PD-L1 in NSCLC

Shanghai Changzheng Hospital

Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡